Korsana Biosciences

About Korsana Biosciences

Korsana Biosciences focuses on developing best-in-class therapeutics to reduce the burden of neurodegenerative diseases, with an emphasis on delivering agents to the central nervous system. The company partners to advance precision-engineered biologics, starting with Alzheimer’s disease, leveraging its THETA platform to overcome the blood-brain barrier and improve CNS exposure. Korsana highlights its pipeline and publications to share progress in creating targeted, CNS-penetrant therapies. The organization positions itself as a biotech company advancing therapeutics for neurodegenerative conditions, with activity and partnerships described on its website.